retatrutide safety profile clinical trials A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity Triple hormone receptor agonist retatrutide
Pay in 4 interest-free payments of $5.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17






/assets/images/provider/photos/2774234.jpeg)




















